Related Experiment Video
Updated: Jul 10, 2025

Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells
Published on: September 1, 2019
SPOP promotes CREB5 ubiquitination to inhibit MET signaling in liver cancer
De-Ao Gong1, Peng Zhou1, Wen-Yi Chang1
1Key Laboratory of Molecular Biology for Diseases (Ministry of Education), Institute for Viral Hepatitis, Department of Infectious Diseases, The Second Affiliated Hospital, Chongqing Medical University, Chongqing 400016, China.
Abstract:
Liver cancer is ranked as the sixth most prevalent from of malignancy globally and stands as the third primary contributor to cancer-related mortality. Metastasis is the main reason for liver cancer treatment failure and patient deaths. Speckle-type POZ protein (SPOP) serves as a crucial substrate junction protein within the cullin-RING E3 ligase complex, acting as a significant tumor suppressor in liver cancer. Nevertheless, the precise molecular mechanism underlying the role of SPOP in liver cancer metastasis remain elusive. In the current study, we identified cAMP response element binding 5 (CREB5) as a novel SPOP substrate in liver cancer. SPOP facilitates non-degradative K63-polyubiquitination of CREB5 on K432 site, consequently hindering its capacity to activate receptor tyrosine kinase MET. Moreover, liver cancer-associated SPOP mutant S119N disrupts the SPOP-CREB5 interactions and impairs the ubiquitination of CREB5.This disruption ultimately leads to the activation of the MET signaling pathway and enhances metastatic properties of hepatoma cells both in vitro and in vivo. In conclusion, our findings highlight the functional significance of the SPOP-CREB5-MET axis in liver cancer metastasis.
Insights
Speckle-type POZ protein (SPOP) suppresses liver cancer metastasis by regulating cAMP response element binding 5 (CREB5) ubiquitination. Disruptions in this SPOP-CREB5 interaction activate MET signaling, promoting cancer spread.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Liver cancer is a leading cause of cancer mortality worldwide.
- Metastasis is a primary driver of treatment failure and mortality in liver cancer patients.
- Speckle-type POZ protein (SPOP) is a tumor suppressor in liver cancer, but its role in metastasis is unclear.
Purpose of the Study:
- To elucidate the molecular mechanism of SPOP in liver cancer metastasis.
- To identify novel SPOP substrates involved in liver cancer progression.
- To investigate the SPOP-CREB5-MET signaling axis in hepatoma cells.
Main Methods:
- Co-immunoprecipitation assays to identify SPOP-CREB5 interaction.
- Ubiquitination assays to detect CREB5 modification at K432.
- In vitro and in vivo assays to assess hepatoma cell metastasis.
- Analysis of SPOP mutant effects on CREB5 and MET signaling.
Main Results:
- cAMP response element binding 5 (CREB5) was identified as a novel substrate of SPOP in liver cancer.
- SPOP mediates non-degradative K63-polyubiquitination of CREB5, inhibiting MET activation.
- A liver cancer-associated SPOP mutant (S119N) impairs CREB5 ubiquitination, leading to MET pathway activation and enhanced metastasis.
- Disruption of the SPOP-CREB5 interaction promotes hepatoma cell migration and invasion.
Conclusions:
- The SPOP-CREB5-MET signaling axis is functionally significant in regulating liver cancer metastasis.
- Targeting the SPOP-CREB5 interaction may offer a therapeutic strategy for liver cancer.
- Understanding SPOP's role in CREB5 ubiquitination provides insights into liver cancer progression.
More Related Videos
10:44Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
Published on: May 15, 2019
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
Related Concept Videos
Induced Pluripotent Stem Cells
Somatic...
Abnormal Proliferation
PI3K/mTOR/AKT Signaling Pathway
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Regulation of Metabolism
Cell Specific Gene Expression